GUÍA TÉCNICA G-BIOF 02: - Instituto de Salud Pública de Chile

Ungel A.L.. Caco -2 replace or refine. Drug Discovery Today, Vol 1 (4):
423-430, 2004
Swanepoel, E.; Liebenberg W.; Davarakonda B.; Villiers M. Developing
a discriminating dissolution test for three mebendazole polymorph
based on solubility differences. Pharmazie 58 (2): 117-121, 2003
Vogelpoel, H., Welink, J., Amidon, G. L., Junginger, H. E., Midha, K. K.,
Möller, H., Olling, M., Shah, V. P., Barends, D. M. Biowaiver
Monographs for Immediate Release Solid Oral Dosage Forms: Verapamil
Hydrochloride, Propranolol Hydrochloride, and Atenolol. J. Pharm. Sci.
93 (8), 1945 – 1956, 2004
WHO, 1996. Multisource (Generic) Pharmaceutical Products: Guidelines
on Registration Requirements to Establish Interchangeability. Technical
Report Series Nº 863, Anexo 9, 115–139.
http://whqlibdoc.who.int/trs/WHO_TRS_863_(p99 p194).pdf
WHO, 2006. World Health Organization Expert Committee on
Specifications for Pharmaceutical Preparations. Fortieth Report, Geneve
Yasdanian N.; Briggs K.; Jankosky C. and Hawi A. The “High Solubility”
definition on the current FDA Guidance on Biopharmaceutical
Classification System may be too strict for acidic drugs. Pharml Res,
21(2): 293-299, 2004
Yu, L. X. Ellison, C. D. Conner, D. P. Lesko, L.J. Hussain, A. S..
Influence of Drug Release Properties of Conventional Solid Dosage
Forms on the Systemic Exposure of Highly Soluble Drugs. AAPS
PharmSci. 3 (24), 1 – 7, 2001
Yu L X., Amidon G. Polli J., Zhao H., Mehta M., Conner D., Shah V.,
Av. Marathón 1000 – Ñuñoa – Casilla 48 – Santiago – Teléfono: 350 74 77 – Código Postal: 7780050 – www.ispch.cl
G-BIOF-02
62